Phase II Trial of Talazoparib in BRCA1/2 Wild-type HER2-negative Breast Cancer and Other Solid Tumors

Clinical trial NCT02401347 · COMPLETED

Trial details

NCT number: NCT02401347
Sponsor: Melinda Telli
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Breast Cancer HER2/Neu Negative Triple-Negative Breast Cancer

Start date: 2015-08-01
Primary completion: 2019-12-23
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.